United States (US) Hereditary Angioedema Market (2025-2031) | Share, Companies, Trends, Outlook, Value, Competitive Landscape, Analysis, Industry, Growth, Segmentation, Forecast, Size & Revenue

Name: United States (US) Hereditary Angioedema Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Others), By Route of Administration (Intravenous, Subcutaneous Injection, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) And Competitive Landscape

Product Code: ETC9967684	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Hereditary Angioedema Market Outlook
Market Size of United States (US) Hereditary Angioedema Market, 2024
Forecast of United States (US) Hereditary Angioedema Market, 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Revenues & Volume for the Period 2021- 2031
United States (US) Hereditary Angioedema Market Trend Evolution
United States (US) Hereditary Angioedema Market Drivers and Challenges
United States (US) Hereditary Angioedema Price Trends
United States (US) Hereditary Angioedema Porter's Five Forces
United States (US) Hereditary Angioedema Industry Life Cycle
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By C1 Esterase Inhibitor for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Selective Bradykinin B2 Receptor Antagonist for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Kallikrein Inhibitor for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Intravenous for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Subcutaneous Injection for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Hereditary Angioedema Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Hereditary Angioedema Import Export Trade Statistics
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Distribution Channel
United States (US) Hereditary Angioedema Top Companies Market Share
United States (US) Hereditary Angioedema Competitive Benchmarking By Technical and Operational Parameters
United States (US) Hereditary Angioedema Company Profiles
United States (US) Hereditary Angioedema Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Hereditary Angioedema Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Hereditary Angioedema Market - Industry Life Cycle

3.4 United States (US) Hereditary Angioedema Market - Porter's Five Forces

3.5 United States (US) Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 United States (US) Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Hereditary Angioedema Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about hereditary angioedema among healthcare professionals and patients

4.2.2 Advancements in diagnostic technologies leading to early detection and treatment

4.2.3 Growing research and development activities focused on developing new therapies and treatment options

4.3 Market Restraints

4.3.1 High cost associated with treatment and management of hereditary angioedema

4.3.2 Limited availability of approved therapies leading to unmet medical needs

4.3.3 Challenges in diagnosis and misdiagnosis of hereditary angioedema due to its rarity and similarity with other conditions

5 United States (US) Hereditary Angioedema Market Trends

6 United States (US) Hereditary Angioedema Market, By Types

6.1 United States (US) Hereditary Angioedema Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F

6.1.4 United States (US) Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F

6.1.5 United States (US) Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F

6.1.6 United States (US) Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Hereditary Angioedema Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 United States (US) Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 United States (US) Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F

6.2.4 United States (US) Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F

6.3 United States (US) Hereditary Angioedema Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 United States (US) Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Hereditary Angioedema Market Import-Export Trade Statistics

7.1 United States (US) Hereditary Angioedema Market Export to Major Countries

7.2 United States (US) Hereditary Angioedema Market Imports from Major Countries

8 United States (US) Hereditary Angioedema Market Key Performance Indicators

8.1 Average time from symptom onset to diagnosis

8.2 Number of clinical trials for new therapies in the pipeline

8.3 Patient adherence rate to prescribed treatment regimens

9 United States (US) Hereditary Angioedema Market - Opportunity Assessment

9.1 United States (US) Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 United States (US) Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Hereditary Angioedema Market - Competitive Landscape

10.1 United States (US) Hereditary Angioedema Market Revenue Share, By Companies, 2024

10.2 United States (US) Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Hereditary Angioedema Market

Estonia Hereditary Angioedema Market

Ethiopia Hereditary Angioedema Market

Fiji Hereditary Angioedema Market

Finland Hereditary Angioedema Market

Gabon Hereditary Angioedema Market

Global Hereditary Angioedema Market

Middle East Hereditary Angioedema Market

North America Hereditary Angioedema Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here